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Abstract
Connexins mediate intercellular communication by assembling into hexameric channel complexes that act as
hemichannels and gap junction channels. Most connexins are characterized by a very rapid turn-over in a variety of cell
systems. The regulation of connexin turn-over by phosphorylation and ubiquitination events has been well documented.
Moreover, different pathways have been implicated in connexin degradation, including proteasomal and lysosomal-based
pathways. Only recently, autophagy emerged as an important connexin-degradation pathway for different connexin
isoforms. As such, conditions well known to induce autophagy have an immediate impact on the connexin-expression
levels. This is not only limited to experimental conditions but also several pathophysiological conditions associated with
autophagy (dys)function affect connexin levels and their presence at the cell surface as gap junctions. Finally, connexins
are not only substrates of autophagy but also emerge as regulators of the autophagy process. In particular, several
connexin isoforms appear to recruit pre-autophagosomal autophagy-related proteins, including Atg16 and PI3K-complex
components, to the plasma membrane, thereby limiting their availability and capacity for regulating autophagy.
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Background
A short overview of the autophagy process
Autophagy (meaning “to eat oneself”) is a term to describe
the intracellular processes responsible for the delivery of
the cell’s own macromolecules to the lysosomes (or vacu-
oles) for degradation and recycling [1]. Three main types of
autophagy can be distinguished based on their mechanism
of delivery. In microautophagy, direct delivery happens
through invagination of the lysosomal membrane, while
chaperone-mediated autophagy relies on molecular chaper-
ones and lysosome-associated membrane protein 2 LAMP2
to guide misfolded proteins to the lysosomes. The best
studied type of autophagy, macroautophagy (hereafter
referred to as “autophagy”), involves the transport and
delivery of intracellular macromolecules or organellar
fragments to the lysosomes inside double-membranous
vesicles (autophagosomes). Due to their relatively large size
(0.5 – 1.5 μm in mammalian cells [2]), autophagosomes
were already discovered by transmission electron micros-
copy in the early sixties and the term “autophagy” launched
by Nobel Prize-winning lysosomal expert Christian de Duve
in 1963 [3]. However, its importance became only acknowl-
edged in 1999, when Levine and co-workers discovered that
a critical autophagy protein, Beclin 1, is a tumor suppressor
[4]. This seminal work and further investigation established
autophagy as a crucial player in cellular life and death
during stress and disease. Indeed, upon nutritional, hypoxic,
chemical or mechanical stress, autophagy is often stimulated,
leading to enhanced degradation and recycling of molecular
components. This way, possibly toxic damaged macromole-
cules, aggregates or organelles can be swiftly removed, espe-
cially those that are too large to be degraded by the
proteasome or when the proteasomal degradation is blocked
[5]. Moreover, lysosome-dependent autophagic recycling cre-
ates a new pool of cellular building blocks to be incorporated
into the required anti-stress proteins. This is particularly
convenient during nutrient deprivation, when non-selective
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bulk recycling of macromolecules ensures the availability of
amino acids and cellular survival. In contrast, specific au-
tophagic degradation of protein aggregates or organelles (e.g.
mitochondria, a process termed mitophagy) is mediated by
specific proteins tagging and sequestering polyubiquitin
chains or damaged organelles. As such, it is clear that au-
tophagy is a self-protective process that removes possible
toxic cell death-inducing signals and enhances survival.
However, in certain situations, autophagy may actually pro-
voke cell death. Although autophagy-dependent cell death
is likely less frequent than pro-survival autophagy and while
its mechanistic details are still unclear, it is a clinically rele-
vant phenomenon (e.g. upon ischemia) [6–8].
To ensure that the formation, transport and fusion of
autophagosomes is correctly executed, a network of mo-
lecular pathways and proteins are involved (Fig. 1). Many
of these players are shared with the endocytic pathway [9].
However, the autophagic pathway also contains a set of
autophagy-specific proteins (Atg proteins) that function
in the formation of the double membranous structure
(phagophore), its subsequent elongation and closure
into an autophagosome and the sequestration of its cargo
[10, 11]. The origin of the phagophore is still debated, with
different organelles postulated as candidates as source of
this lipid bilayer [12]. This likely depends on the type of
stress that induces autophagy and the material that needs
to be degraded (specific organelles or structures or non-
selective cytoplasmic in bulk degradation). At the endoplas-
mic reticulum (ER), clear observations have been made of
the phagophore gradually originating and protruding from
PtdIns(3)P-rich sites called omegasomes [13, 14]. This is
mediated by the phosphoinositide 3-kinase (PI3K) Class III
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Fig. 1 Macroautophagy is a major recycling pathway for long-lived proteins, protein aggregates and organelles. Autophagy induction is controlled by the
AMPK/mTOR-signaling axis. In nutrient-rich conditions, AMPK activity is low and mTOR activity is high, thereby suppressing the autophagic pathway. Upon
nutrient starvation and/or energy deprivation, AMPK activity is high, causing the inhibition of mTOR (directly and indirectly via the TSC1/2-Rheb GTPase
pathway) and activation of the ULK1 complex involving a complex network of phosphorylations. mTOR inhibition and autophagy activation can also
be achieved in nutrient-rich conditions using chemical mTOR inhibitors like rapamycin. Activation of the ULK1 complex contributes to the activation
of the class III PI3K complex (Atg14L/Beclin 1 (Atg6)/Vps34 and the Vps34-regulatory protein Vps15 (not shown)) by phosphorylating Beclin 1, producing
PtdIns(3)P from PtIns at the pre-autophagosomal structures (PAS) necessary for the formation of the phagophore. This structure then elongates
into a double-membranous vesicle, the autophagosome, by recruitment of the Atg12/Atg5/Atg16 complex and the lipidation of LC3-I into
phosphatidylethanolamine-conjugated LC3-II. LC3-II formation involves the production of LC3-I by Atg4-mediated proteolytic cleavage of LC3 and the
action of E1-like ligases (Atg7), E2-like ligases (Atg3) and E3-like ligase complexes (Atg12/Atg5/Atg16L1). Furthermore, ubiquitin-binding proteins like p62
can bind LC3, thereby linking ubiquitinated proteins to LC3-II and targeting them for autophagic degradation. The Atg12/Atg5/Atg16 complex present in
the outer membrane dissociates from mature autophagosomes, which then fuse with the lysosomes, degrading the inner membrane and the cargo
present in the autophagosomes via luminal hydrolysases and subsequently releasing the digested material via permeases back into the cytosol. The fusion
of autophagosomes with lysosomes can also involve endosomes, leading to intermediate amphisome formation
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complex, consisting of (among others) Vps34, Vps15, Beclin
1 (Atg6) and Atg14L, which phosphorylates PtdIns to
PtdIns(3)P. The PtdIns(3)P signal recruits several proteins
(e.g. WIPI1 and2 (Atg18) [15] that induce the protrusion of
the phagophore from the ER membranes. PI3K Class III ac-
tivity is regulated by the nature of its interacting partners
(including anti-apoptotic proteins Bcl-2 and Bcl-XL [16,
17]) and by the ULK1/2 complex [18]. The latter consists
of ULK1/2, Atg13 and FIP200 and mediates the response
of autophagy towards nutrient availability and energy sta-
tus, as it is regulated by the nutrient sensing kinase mTOR
and the energy sensing AMP-dependent kinase AMPK,
respectively. mTOR inhibits the ULK1/2 complex by
phosphorylation when amino acids and growth factors are
abundant. When nutrients are scarce however, mTOR ac-
tivity is repressed and ULK1/2 active. Upon energy
deprivation, AMPK phosphorylates ULK1/2 at different
sites than mTOR, activating the complex [19], which stim-
ulates PI3K Class III and triggers the formation of the
phagophore. AMPK also inhibits mTOR activity by phos-
phorylating TSC1/TSC2 (tuberous sclerosis complex 1
and 2), thereby suppressing RHEB (Ras homologue
enriched in brain) activity [20]. Further elongation of the
phagophore is mediated by delivery of novel lipids trans-
ported by lipid carrier protein Atg9 [21], and by two
ubiquitin-like reaction processes that are dependent on
Atg7 [10, 22]. First, Atg5 is covalently linked Atg12 by
Atg7 (E1-like) and Atg10 (E2-like). The Atg5-Atg12 com-
plex then binds Atg16L1, resulting in an Atg12-Atg5-
Atg16L1 complex that attaches to the autophagosomal
membranes. Second, LC3-I is generated from the LC3
precursor mediated by proteolytic cleavage by Atg4 and
becomes lipidated in a series of ubiquitin-like reactions
executed by E1-like (Atg7), E2-like (Atg3) and E3-like
(Atg12-Atg5-Atg16L1) enzymes, resulting in LC3-II [11].
These reactions are crucial for the autophagy process, as
Atg5-, Atg7-deficient mice and cells lack autophagic
features [23, 24], although in specific tissues, Atg5 and
Atg7-independent autophagy has been described [25].
LC3-II attaches to the autophagosomal membrane. This is
exploited to determine the amount of autophagosomes by
LC3-II detection. However, this does not necessarily reflect
autophagic activity, since an inhibition of autophagosome-
lysosome fusion too can lead to an accumulation (and thus
increase) of autophagosomes [26]. As such, LC3 data are
often obtained in the absence and presence of lysosomal
inhibitors and combined with experiments determining the
levels of Sqstm1/p62, a long-lived protein, in order to
carefully assess autophagic flux. This autophagy re-
ceptor links the cargo (e.g. polyubiquitin) to LC3-II at
the autophagosomal membranes to be sequestered.
Ultimately, p62 is degraded in the lysosomes, making
its levels a valuable marker for the autophagic degrad-
ation rate [27].
Here, we will focus on the emerging role of autophagy
as a novel connexin-turnover pathway with a brief sum-
mary of the earlier work implicating proteasomal and
endosomal/lysosomal pathways for which we would like
to refer to the many excellent and recent reviews on this
topic published elsewhere [28–31].
Connexin turnover and degradation by
proteasomal and lysosomal pathways
Connexin proteins, together with pannexins and CALHM1,
form the basis for intercellular communication between
cells and cell types in different tissues and organs [32, 33].
Hexameric connexin structures, called “connexons”, form
the functional units, being unopposed hemichannels or
head-to-head docked gap junctions, providing flux path-
ways for a variety of ions, amino acids, nucleotides, metabo-
lites and signaling molecules with molecular weights below
1.5 kDa and small RNA molecules. Cx43, which represents
the 43-kDa connexin protein, is the most abundant con-
nexin ubiquitously expressed in a plethora of tissues and
organs. As gap junctions, connexins control a plethora of
cellular and physiological processes, including the regula-
tion of cell growth, migration, apoptosis, and cell signaling
[34–37]. Gap junction dysregulation has been implicated in
different pathophysiological conditions, including ischemia/
reperfusion in the heart, epilepsy, inflammation, neurode-
generation and myocardial infarctions [38–40]. Different
mutations in connexin-encoding genes causing dysfunc-
tional, mislocalized or downregulated gap junctions have
been linked to human diseases such as cardiovascular
diseases, congenital deafness, skin diseases, myelin-related
diseases and cataracts [41–43]. Recently, hemichannels too
have been emerging as important signaling hubs not only
in pathophysiology (like ischemia reperfusion in brain and
heart tissues), but also in physiology [44], like in fear mem-
ory consolidation in astroglia of the basolateral amygdala
[45], in osteocyte viability important for bone structure,
integrity and function [46, 47] and as natural oncosuppres-
sors that counteract cancer growth and metastasis to the
bone [48].
Importantly, connexin gap junction complexes are very
dynamically different regulated in a variety of physiological
and pathophysiological conditions in different cell types
and systems (reviewed in [49]). In comparison to other
membrane proteins characterized by half-lives between 17
and 100 h, the turnover of connexin proteins is very rapid,
between 1.5 and 5 h in various cell lines, cell types and
tissue [49]. Rapid degradation may be an important mech-
anism for adjusting intercellular coupling of cells under
normal and pathophysiological conditions. As an excep-
tion, a subpopulation of connexins expressed in the lens,
like Cx45.6, Cx46 and Cx56 has a prolonged half-life (up
to days) [49]. The turnover of connexin gap junctions is
also dynamically regulated in response to physiological
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and pathophysiological conditions, including the response
to EGF, phorbolesters or injury. This involves a well-
characterized cascade of phosphorylation events [50]. For
instance, Akt phosphorylation on Cx43 Ser373 promotes
Cx43 gap junction assembly in an open state in response
to EGF/injury, which is followed by a MAPK-mediated
phosphorylation of Ser278/Ser282, closing gap junction,
and a Src-mediated phosphorylation of Tyr247 causing
Cx43 gap junction internalization [50, 51]. Degradation of
Cx43 gap junctions may occur via the degradation of the
“oldest subdomains” (i.e. containing the “oldest proteins”)
within the gap junction or via the internalization of the
complete gap junction in a double membranous structure,
called an “annular” junction or “connexisome” [50, 51].
This internalization of Cx43 gap junctions occurs at least
in part via small endocytic double-membrane vesicles [52]
in a clathrin-dependent manner [53, 54]. A plethora of
studies revealed that the degradation of Cx43 proteins
involve proteasomal and lysosomal pathways, including
autophagy. The dynamic regulation of Cx43 gap junction
size and levels by phosphorylation events triggered by
physiological and pathophysiological stimuli is discussed
elsewhere in different excellent reviews by others [50, 51].
Seminal work by Beyer and his team showed a prominent
role for the ubiquitin-dependent proteasome as a major
connexin-turnover pathway in normal conditions and stress
conditions like heat stress [55]. Inhibitors of the prote-
asome significantly increased the half-life of Cx43 proteins
in pulse-chase experiments. Besides pharmacological ap-
proaches, his team also used genetic-based approaches
thereby elegantly comparing the turnover of Cx43 in E36
chinese hamster ovary cells and in E36 cells containing a
temperature-sensitive version of the ubiquitin-activating
protein, E1 (ts-E36). The ts-E36 cells are defective in the
proteasomal degradation of short-lived or abnormal pro-
teins at high temperatures (39 °C) but not at low tempera-
tures (30 °C). While Cx43-protein levels were similar in
E36 and ts-E36 cells at low temperatures, Cx43-protein
levels were prominently higher in ts-E36 cells than in wild-
type E36 cells at high temperatures. The decline of Cx43 in
E36 cells could be rescued by proteasomal inhibitors. Con-
sistent with these findings, Cx43-ubiquitin conjugates could
be identified in lysates of E36 cells treated with proteasomal
inhibitors. A similar role for proteasomal degradation of
Cx43 was described in rat heart-derived BWEM cells in
which the loss of plasmalemmal Cx43 triggered by treating
the cells with brefeldin A or monensin could be prevented
by proteasomal inhibitors. Follow-up studies based on
primary cultures from neonatal rat ventricular myocytes
demonstrated that heat stress could enhance Cx43 degrad-
ation by the proteasome [56]. Interestingly, heat shock
protein 70, upregulated in response to heat stress, emerged
as a protective factor preventing Cx43 degradation upon
repeated heat stress stimuli.
The proteasome not only appears to be important for
plasmalemmal Cx43 degradation, but likely assists in the
ER-associated degradation (ERAD) mechanism (Fig. 2) of
Cx43 dislocated from the ER of cells exposed to cellular
stress (like in cells exposed to the reducing agent DTT)
[28, 57]. Further molecular studies provided evidence that
ER-localized Cx43 could directly interact with a 75-kDa
protein [58, 59], named Cx43-interacting protein of 75-
kDa or CIP75. This protein belongs to the ubiquitin-like
(UbL) and ubiquitin-associated (UBA) domain protein
family [60]. UBL/UBA-domain-containing proteins serve
as shuttle/adapter proteins interacting on the one hand
with ubiquitinated targets and on the other hand with the
Rpn1 and Rpn10 subunits of the 19S regulatory particle,
Cx43 degradation
ER
Proteasome
ER translocation
Nucleolus
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CIP75
CIP75
Cx43
Fig. 2 Proteasomal degradation of Cx43 via ERAD: CIP75 binds to the C-terminal tail of ER-localized Cx43 via its UBA domain, and then facilitates
the translocation of Cx43 from the ER membrane into the cytosol. This complex interacts with 19S proteasome subunit via the CIP75 UBL domain,
leads to the proteasomal degradation
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which together with the 20S core particle forms the 26S
proteasome holoenzyme [58, 60]. Here, the UBA domain
of CIP75 directly bound to the carboxyl terminus (CT) of
Cx43 via a low-affinity interaction (Kd of about 300 μM),
involving several regions within the intrinsically disorder
part of the CT tail of Cx43 [61]. Further studies confirmed
the presence of a multi-protein complex involving ER-
localized Cx43/CIP75/Rpn1/Rpn10 [62] in which CIP75 is
essential for the interaction of Cx43 with the proteasomal
components. CIP75 controlled Cx43 half-life, which in-
creased in the absence of CIP75 and decreased upon
CIP75 overexpression [58]. CIP75-induced Cx43 degrad-
ation could be prevented by proteasomal inhibitors. Inter-
estingly, although CIP75 directly interacts with different
ubiquitinated proteins, including the well-documented p27
(Cip/Kip family of cyclin dependent kinase inhibitor 1B
(CDKN1B)), to direct them to the proteasome for degrad-
ation, the interaction of CIP75 with ER-localized Cx43
occurred in an ubiquitin-independent manner [59]. Indeed,
ER-localized Cx43 co-immunoprecipitated with CIP75 was
not ubiquitinated, while immunoprecipitation of ubiquiti-
nated proteins did not yield any Cx43. This finding was
corroborated by experiments showing the binding of
CIP75 to lysine-mutated Cx43, void of potential ubiquitin-
acceptor sites. Further experiments indicated that the
interaction of CIP75 with Cx43 was increased upon mis-
folding of the Cx43 protein, either induced by mutations
or by DTT [62]. Hence, CIP75 was proposed to facilitate
the dislocation of Cx43 from the ER membranes into the
cytosol, where it can be targeted to the proteasome for
degradation by associating with the Rpn1 and Rpn10 com-
ponents [62]. Very recently, the role of CIP75 in the pro-
teasomal degradation of connexin proteins appeared not to
be limited to the Cx43 isoform, but also impacted the deg-
radation of other connexin isoforms, including Cx40 and
Cx45 [61]. Similarly as for Cx43, the UBA domain of
CIP75 was found to directly interact with the CT regions
of Cx40 and Cx45 via low-affinity interactions involving
several intrinsically disordered regions, which were not
conserved among the different Cx43, Cx40 and Cx45
proteins. Consistent with these molecular findings, CIP75
levels affected the degradation of Cx40 and Cx45 proteins,
in which CIP75 shRNAs augmented Cx40- and Cx45-
protein levels, likely by hampering their proteasomal
degradation via ERAD. This is supported by the fact that
cells expressing ER-targeted Cx40 or Cx45, treated with
brefeldin A/DTT to induce Cx40 or Cx45 misfolding and
degradation by ERAD, displayed augmented Cx40/
CIP75 or Cx45/CIP75-complex formation and co-
localization at the ER membranes. Besides Cx40, Cx43
and Cx45, also Cx32 appears to be degraded via the
proteasome involving ERAD, but this likely involves the
canonical ubiquitination pathway of Cx32 [57, 63, 64].
This appears to be supported by biochemical evidence
that CIP75 could be co-immunoprecipitated with cellu-
lar Cx32 but not with the bacterially expressed and
purified CT of Cx32 [61]. Proteasomal degradation has
also been implicated in the turnover of pathological
mutant connexin channels that are inherently unstable
[65]. For instance, a frame shift mutation in Cx50 caus-
ing recessive congenital cataract resulted in an unstable
Cx50 protein that is rapidly degraded via ERAD and
the proteasome, thereby reducing Cx50 gap junctions
and impairing intercellular communication [65]. Epoxo-
micin, a proteasomal inhibitor, prevented the degradation
of the mutant Cx50 protein, increasing Cx50-protein
levels and their presence as functional gap junctions, cap-
able of restoring intercellular coupling.
However, early on in connexin research, it became also
very clear that lysosomal pathways contributed to the con-
nexin degradation, potentially as a minor component in
normal physiological conditions, but gaining more import-
ance upon stress [55, 66]. Lysosomotropic amines slightly
increased the half-life of Cx43 in response to heat stress
[55]. However, follow-up studies showed that endogenous
Cx43 levels were about 4-fold higher in BWEM cells
exposed to proteosomal or lysosomal inhibitors than in
untreated BWEM cells [66]. In brefeldin A-induced Cx43-
degradation experiments, proteasomal and lysosomal in-
hibitors appeared both effective in counteracting Cx43
degradation. Also, brefeldin A caused internalization of
Cx43 gap junction, as a step preceding degradation. Strik-
ingly, proteasomal inhibitors could largely restore the
presence of Cx43 in gap junctional plaques at appositional
membranes in brefeldin A-treated cells, while lysosomal
inhibitors were much less effective. In the latter, Cx43 gap
junctions mainly appeared in intracellular vesicles. Differ-
ent studies provided evidence for endolysosomal Cx43
degradation (reviewed in [28]). Plasmalemmal Cx43 gap
junctions internalized via the endocytic pathway and
subsequently fused with lysosomal structures (Fig. 3). As
discussed elsewhere [29], Cx43 internalization depended
on the presence of clathrin, clathrin-adaptor proteins (in-
cluding AP-2 and Dab2) and dynamin 2 and on dynamin
GTPase activity. Also, the Cx43-interacting protein of
85 kDa, CIP85, an ubiquitously expressed Rab GTPase-
activating protein, emerged as a critical factor for Cx43
internalization and lysosomal degradation [67]. CIP85 co-
localized with Cx43 at the cell surface by means of a direct
interaction between CIP85 and Cx43, involving the SH3
domain and the proline-rich region P253LSP256, respect-
ively. Overexpression of CIP85, but not CIP85 lacking its
SH3 domain, increased Cx43 turnover likely by recruiting
clathrin and subsequently enhancing Cx43 internalization
as gap junctions from the plasma membrane [67]. Strik-
ingly, lysosomal inhibitors, such as NH4Cl or leupeptin,
but not proteasomal inhibitors, such as MG132, prevented
the increased turnover of Cx43 by CIP85 overexpression
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[68]. Further studies showed the accumulation of connex-
ins in lysosomes in cells exposed to lysosomal inhibitors,
preventing their degradation and correlating with an in-
creased appearance of Cx43 at the cell surface in such
conditions [69].
Autophagy: an emerging connexin-degradation
pathway
Besides the endosomal/lysosomal pathway, in recent years,
autophagy emerged as an important connexin-degradation
pathway. This is supported by electron microscopic obser-
vations made about 30 years ago showing the presence of
gap junctions in autophagic structures, the typical double
membrane vesicles containing cellular material [52]. How-
ever, only recently, mechanistic insights in the role of
autophagy for connexin turnover have been obtained.
Basic molecular mechanisms underlying connexin
degradation by autophagy
The first direct evidence for a role of autophagy in con-
nexin degradation was provided by the work of Beyer and
his team [70]. Nutrient starvation, a potent inducer of the
canonical mTOR-controlled autophagy pathway, triggered
a rapid decline in the protein levels of wild-type Cx50,
ectopically expressed in HeLa cells, and of wild-type
Cx43, endogenously expressed in NRK cells. Nutrient star-
vation periods of just 2 h already impacted Cx43- and
Cx50-protein levels. This corresponded with a marked
decline in Cx43 and Cx50 levels at the plasma membrane
and in perinuclear regions and a prominent increase in
cytosolic LC3-positive autophagosomal punctae that
stained positive for Cx50. About 1/3 of the intracellular
Cx50 co-localized with LC3 in cells undergoing starvation
for 4 h. Also, p62, another autophagic marker, could be
detected in punctae that co-localized with intracellular,
but not plasmalemmal, Cx50 or Cx43. Importantly, intra-
cellular connexin gap junctions appeared in intracellular
double membrane vesicles that were in close proximity of
the endoplasmic reticulum, a hall-mark of autophagosome
formation and autophagy. Basal autophagy appeared to
contribute to the normal turn-over of Cx50 and Cx43 pro-
teins, since chloroquine, a lysosomal inhibitor, caused an
increase of about 30 % in basal Cx50-protein levels in
transfected HeLa cells and of more than 100 % in basal,
endogenous Cx43-protein levels in NRK cells, both grown
in normal, nutrient-rich medium conditions. In these cell
systems, chloroquine largely prevented the starvation-
induced decline in Cx50- and Cx43-protein levels. These
observations correlated with the co-localization of LC3
with both Cx50 and Cx43 under normal growth condi-
tions, suggesting connexin turnover by basal autophagy
and an increased co-localization during starvation periods
(in the presence of chloroquine to prevent connexin
degradation). Also depleting cells of Atg (autophagy-re-
lated) proteins, essential for autophagic flux, impacted
connexin-protein levels. Knocking down Atg5 caused an
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Fig. 3 Endolysosomal degradation: CIP85 interacts with Cx43 via SH3 domain at plasma membrane. Initiation of clathrin-mediated endocytosis
starts at PtdIns(4,5)P2-rich sites in the plasma membrane where the AP2 adaptor complex associates and recruits further accessory proteins. AP2
complexes connect the cargo membrane protein to clathrin coat. GTPase dynamin is necessary for movement of the vesicle and cargo into the
cell. Internalized Cx43 are degraded via lysosomal degradation
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increase of about 50 % in the basal Cx50-protein levels in
non-starved HeLa cells and largely prevented the
starvation-induced decline in Cx50-protein levels in
starved HeLa cells. Similar results were obtained for Cx43
in MEF cells, in which Atg5-knockout MEF did not dis-
play any decline in Cx43-protein levels upon starvation.
This study also implicated autophagy as an important deg-
radation pathway for mutant Cx50 proteins, like Cx50P88S
associated with cataract. In fluorescent microscopy experi-
ments, cytoplasmic accumulation of Cx50P88S co-localized
with the endogenous autophagosomal markers LC3 and
p62, and with the lysosomal markers LAMP1. Consist-
ently, starvation caused a major decline in the Cx50P88S-
protein levels compared to non-starved conditions. The
co-localization of p62 with Cx43 and Cx50 might imply a
role for p62 in targeting connexins to the autophagic
machinery for degradation, given p62’s role as a linker
protein between ubiquitinated proteins and LC3.
In subsequent work by Cuervo and co-workers [71],
molecular determinants controlling Cx43 degradation by
autophagy were elucidated. In this study, it was shown
that several endogenously expressed connexins, Cx26,
Cx32 and Cx43, in the liver were present in autophagic
vesicles (autophagosomes and autophagolysosomes) and
co-fractionated with LC3. Connexin accumulation in the
autophagic vesicles became more pronounced in liver
samples starved for 6 h and in cultured cells from which
serum was removed. Depletion of essential autophagy
proteins in cells by Atg7 knockdown or Atg5 knockout
prevented the degradation of connexins in response to
serum removal. Similar effects were obtained using 3-
methyladenine, a PI3K inhibitor that inhibits autophagy
by suppressing autophagosome formation. Using photo-
switchable Dendra-fused connexins to track de novo
synthesized proteins as red fluorescent proteins, it was
observed that serum-starvation caused the rapid degrad-
ation of Cx26, Cx32 and Cx43. However, in contrast to
Cx26 and Cx32, Cx43 could be completely rescued by
Atg7 knockdown, implying different roles for autophagy
in the degradation of different connexin isoforms.
Consistent with these findings, serum removal caused
Cx43 relocalization from the plasma membrane to
autophagosomes. The presence of Cx43 in these LC3/
p62-positive vesicles was enhanced upon treatment with
lysosomal inhibitors. In serum removal conditions, the
degradation of Cx43 appeared to be mediated via the
lysosomes but not the proteasome, since proteasomal
inhibitors (MG132 or lactacystin) did not prevent the
decline in Cx43-protein levels. Further cell surface biotinyl-
ation and confocal microscopy experiments revealed that
mainly Cx43 gap junctions are rapidly degraded by autoph-
agy in conditions of nutrient starvation. As a consequence,
Cx43 remained present in the plasma membrane of starved
cells treated with 3-MA or in which Atg5 or Atg7 was
ablated. These findings were supported by in vivo evidence
in liver-specific ATG7-knockout mice, displaying increased
Cx43 levels and enhanced appearance of Cx43 at the
plasma membrane. These molecular findings were also
supported by evidence obtained at the functional level.
Intercellular dye spreading, a measure for gap junctional
coupling, was markedly declined upon nutrient starvation,
while this decline could be alleviated upon chemical or
genetic inhibition of autophagy. In addition, a link between
internalization and autophagy was established. Indeed, lin-
dane caused Cx43 internalization and degradation involving
a time-dependent and autophagy-dependent redistribution
of Cx43 from the plasma membrane to late endosomal/
lysosomal vesicles identified by LAMP-1. The requirement
of Cx43 internalization for its autophagic degradation was
further elegantly illustrated by the use of the endocytosis-
deficient Cx43Y286A mutant. Interestingly, in contrast to
wild-type GFP-Cx43, GFP-Cx43Y286A persisted at gap junc-
tions in the plasma membrane in starved cells. The intern-
alization and autophagic degradation of Cx43 appeared to
be dependent on ubiquitination of Cx43 by Nedd4 (Fig. 4a)
and the further recruitment of the endocytic protein epi-
dermal growth factor receptor substrate 15 (Eps15).
Nedd4, an ubiquitin ligase enzyme, was previously impli-
cated in binding the C-terminus of Cx43 and mediating
Cx43 ubiquitination [72–74]. Eps15, an endocytic adaptor
protein containing ubiquitin-binding domain, was previ-
ously identified to interact with ubiquitinated Cx43 and
promote its internalization [74]. Serum starvation induced
Nedd4-dependent ubiquitination of Cx43, but not of the
Cx43Y286A mutant, before its accumulation in autophago-
somes [71]. Cx43 expressed in Nedd4-deficient cells was
resistant to degradation by nutrient starvation. These find-
ings were corroborated by showing that ectopically
expressed Cx43, but not Cx43Y286A, fused to a single ubi-
quitin molecule was rapidly degraded in an autophagy-
dependent manner in response to nutrient starvation. It
was here confirmed that p62 served as cargo-recognition
factor, forming a bridge between ubiquitinated Cx43 and
LC3. Cx43-p62 interaction was enhanced during starva-
tion, but was strongly diminished in cells lacking Nedd4.
Furthermore, a critical role for Eps15 was identified in the
early steps of Cx43 degradation.Cx43-Eps15 interaction
was enhanced upon starvation, directing Cx43 for autopha-
gic degradation. In cells lacking Eps15, Cx43 persisted at
gap junctions in the plasma membrane upon nutrient
starvation. Cx43-Eps15 interaction did not require autoph-
agy, since cells lacking Atg5 or Atg7 or treated with 3-MA
even displayed higher levels of Cx43-Eps15-complex for-
mation. However, ubiquitination of Cx43 was critical for
Eps15 interaction, since Cx43Y286A and Cx43 expressed in
Nedd4-deficient cells failed to recruit Eps15 in response to
serum starvation. Excitingly, in this study [71], Eps15 was
also identified as a novel autophagy cargo recognition
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molecule, given its ability to interact with LC3 in LC3-
immunoprecipitation assays and its ability to recruit LC3
and Cx43 in Eps15-immunoprecipitation assays. In any
case, these data revealed autophagy as a major turn-
over pathway for Cx43 via a mechanism that involves
Nedd4-dependent ubiquitination, recruitment of Eps15
and associations with the autophagic machinery, thereby
facilitating Cx43 gap junction internalization and autopha-
gic degradation via the lysosomes.
A detailed ultrastructural, microscopy-based study also
revealed autophagy as a major clearance/degradation path-
way for internalized annular gap junctions from the
cytoplasm [75]. Internalized annular gap junctions appeared
to co-localize with autophagosomal cargo, sequestration
and degradation markers, like p62, RAB-7 and LC3.
Double-membrane phagophore formation could be ob-
served around annular gap junctions, eventually resulting
in lysosomal degradation. Interfering with autophagy using
pharmacological agents or by knocking down essential
autophagy or cargo proteins increased total Cx43-protein
levels and augmented the number of Cx43-containing an-
nular gap junctions. It was postulated that these annular
gap junctions resemble large and complex protein/vesicular
structures (e.g. like protein aggregates, multi-protein com-
plexes, damaged organelles and pathogens) that are typic-
ally removed from the cytoplasm via autophagy rather than
via the proteasome [75]. However, a subset of the annular
gap junctions could be directed to the lysosomes via the
endosomal system, as has been observed for hyperpho-
sphorylated and hyperubiquitinated Cx43 in response to
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Fig. 4 Connexin degradation by autophagy pathway: a Nedd4 mediates ubiquitination of Cx43 (shown Cx43 subunit) in gap junction plaques
and recruits Eps15 to gap junctions upon nutrient starvation. Eps15 can interact with Cx43 via ubiquitin-binding domain, thereby promoting its
internalization. Upon starvation, Cx43-p62-LC3 interaction can direct Cx43 for autophagy degradation. b In normal conditions, autophagosome
precursor proteins such as PI3K complex (Beclin 1, Vps34 and Vps15) and Atg16 are associated with Cx43 (as Cx-Atg complex) at the plasma
membrane. The Cx-Atg complex negatively regulates autophagy. During starvation, the arrival of Atg14 and Atg9 to the Cx43-enriched plasma
membrane, activates Vps34 kinase, thereby inducing internalization of the Cx-Atg complex and the delivery of these pre-autophagosomal components
to the sites of autophagosome formation. Internalization of Cx43 requires the presence of Eps15 (not shown). For clarity reasons, the internalization of
only one Cx43 subunit is shown in both channels
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chemical PKC hyperactivation [76]. Shuttling of ubiquiti-
nated Cx43 from endosomes to lysosomes appears to be
dependent on two ubiquitin-binding proteins, namely Hrs
(hepatocyte growth factor-regulated tyrosine kinase sub-
strate; also known as Hgs) and Tsg101 (tumor susceptibil-
ity gene 101) [77]. Another recent ultrastructural study
revealed that annular gap junctions could be recycled to
the plasma membrane or degraded via three pathways, in-
cluding endo-lysososomal pathways, autophagosomal path-
ways and a direct engulfment by lysosomes [78].
Connexin degradation by autophagy in different cellular
and physiological systems and pathophysiological
conditions
An increasing number of studies report an emerging role
for autophagy as the turnover pathway of connexins in
pathophysiological conditions and diseases, including is-
chemic insults and cancers.
Low pH in pancreatic acinar cells
Besides starvation, low pH, a condition known to uncouple
connexin gap junctions in heart [79], has been implicated
in the degradation of Cx32 gap junctions present in pancre-
atic acinar cells [80]. In particular, low pH in combination
with cerulein, which triggers IP3-induced Ca
2+ oscillations
synchronized by gap junctions, caused a striking decline in
Cx32-protein levels and Cx32 gap junction-mediated coup-
ling of acinar cells. In these conditions, Cx32 gap junctions
were lost and rapidly turned over, correlating with a punc-
tate intracellular localization. The decline in Cx32-protein
levels by the low pH/cerulean treatment could be prevented
by lysosomal inhibitors and by the PI3K/autophagy inhibi-
tor 3-MA. However, also proteasomal degradation path-
ways appeared to contribute to Cx32 degradation in this
system. In another study, cadmium-induced toxicity in BRL
3A rat liver cells was linked to an increase in autophagic
markers and an upregulation of essential autophagy pro-
teins Atg5, Atg7 and Beclin 1. This coincided with a
decrease in Cx43-protein levels and gap junctional coup-
ling, which could be counteracted by lysosomal inhibitors
and aggravated by the autophagy-inducer rapamycin.
Heart failure and ischemia in the heart
A first study focusing on normal and failing heart was able
to link autophagic markers to lateralized and subsequently
internalized Cx43 gap junctions in cardiomyocytes [81]. In
normal hearts, Cx43 gap junctions appear at the interca-
lated disc region of the cardiomyocyte plasma membrane
to properly propagate and spread electrical signals coord-
inating heart contractions. In failing hearts, Cx43 gap
junctions relocalize to lateral cell membranes. In these
failing hearts, Cx43 gap junctions became internalized and
appeared in multilamellar membrane structures. The
membranes appeared to contain buoyant, cholesterol and
sphingolipid-rich membrane domains (referred to as lipid
raft or LR membrane domains), in which a subset of the
Cx43 gap junction population can be accumulating. Inter-
estingly, in failing hearts, the total Cx43 protein levels de-
clined correlating with an increased accumulation of the
Cx43 protein in these LR membrane domains compared
to the Cx43 levels in LR membrane domains from normal
hearts. These structures also resembled the properties of
autophagosomes and accumulated the lipidated protein
LC3-II, which too became upregulated in failing hearts.
As such, the LR fractions contained both Cx43 and LC3
protein. Interestingly, Cx43 and GFP-LC3 co-localized in
intracellular punctae resembling autophagosomes in HeLa
cells and in neonatal rat ventricular cardiomyocytes. How-
ever, this study did not show whether autophagy or its
increased flux was responsible for the turnover and deg-
radation of the Cx43 gap junctions.
Further work on the cardiac system focused on the role
of autophagy in degrading Cx43 upon ischemia and ische-
mia/reperfusion. Ischemia/reperfusion has been associated
with excessive autophagy induction in different physio-
logical systems like the heart [82], liver [83] and kidneys
[84], resulting in detrimental effects like autophagy-
dependent cell death or autosis [85]. In the cardiomyocyte
cell line HL-1, ischemia diminished total Cx43-protein
levels and plasmalemmal Cx43 levels, including hemi-
channels and gap junctions [86]. This decline in Cx43
could be partially rescued by lysosomal inhibitor Bafilomy-
cin A, implying ischemia-induced Cx43 degradation by
autophagy in HL-1 cells. These observations correlated
with an increased appearance of autophagosomes, LC3-II
accumulation, GFP-LC3-punctae formation and Cx43-
LC3 co-localization in HL-1 during ischemia. These find-
ings were also observed in organotypic heart slices and in
Langendorff heart preparations. Functionally, ischemia in
HL-1 reduced intercellular coupling via gap junctions,
which could be rescued by the autophagy inhibitor 3-MA.
Consistent with previous studies, a “proximal” role for
Eps15 was found for the internalization of Cx43 that be-
came ubiquitinated during ischemia and a more “distal”
role for p62 for the targeting of the internalized, ubiquiti-
nated Cx43 to the autophagic machinery. Unexpectedly,
while Nedd4 controlled ubiquitination of Cx43 and im-
pacted basal Cx43 level in HL-1 cells, ischemia-induced
ubiquitination and degradation of Cx43 was not altered in
HL-1 cells in which Nedd4 was knocked down. This
suggests that other E3 ubiquitin ligases may be involved in
ubiquitination of Cx43 during ischemia. Also ischemia/re-
perfusion caused Cx43 degradation in a more excessive
manner than ischemia alone. Cx43 degradation too relied
on autophagy, although 3-MA added only during reperfu-
sion could not prevent Cx43 degradation, implying an
important role for Cx43-containing autophagosomes that
have been accumulating during the ischemia period.
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Interestingly, AMP-activated kinase (AMPK) and Beclin 1
appeared to play different key roles in the Cx43 degrad-
ation upon ischemia versus ischemia reperfusion. Early on
during ischemia, AMPK is robustly activated, implying a
marked decline in cellular ATP levels. Chemical inhibition
of AMPK could partially prevent ischemia-induced Cx43
degradation during these early periods of ischemia. Ex-
tended periods of ischemia led to a decline in AMPK activ-
ity and a failure of the AMPK inhibitor to stabilize Cx43.
During these extended periods, Beclin 1 appeared import-
ant, since siRNA against Beclin 1 could prevent Cx43
degradation during the longer ischemia periods. During
ischemia/reperfusion, only Beclin 1 siRNA but not AMPK
inhibition was effective in preventing Cx43 degradation.
Thus, these data imply different molecular autophagy key
players become activated during the different periods of
ischemia and ischemia/reperfusion, ultimately controlling
Cx43 degradation. Very interestingly, a recent study aiming
to document the proteomic changes associated with the
susceptibility of neonatal versus adult murine hearts to is-
chemia/reperfusion reported an increase in Cx43 levels but
a decrease in Beclin 1 levels upon maturation [87].
Oncogenesis in different tumors
Both altered autophagy [88, 89] and altered connexin
expression [90–92] have been implicated in oncogenesis in
a variety of tumors. In particular, in a variety of tumors con-
nexin gap junctions appear to be downregulated [93], yet
the contribution of autophagy in oncogenic connexin
downregulation is definitely not clear. Nevertheless, a num-
ber of studies appear to suggest the involvement of autoph-
agy in connexin turnover in tumors.
For instance, in non-small cell lung cancer cells (NSCLC),
autophagy is responsible for the rapid degradation and
downregulation of the Cx31.1. isoform. In H1299, a NSCLC
cell line, Cx31.1 overexpression resulted in an intracellular
localization of the protein, consistent with the very rapid
turn-over of Cx31.1 in these cells. The rapid turnover of
Cx31.1 could only be partially prevented by proteasomal
inhibitors. Moreover, autophagy-inducing conditions like
starvation and brefeldinA further increased the rapid
decline in Cx31.1 that was only mildly impacted by
proteasomal inhibitors. In contrast, knockdown of Atg5
prominently protected Cx31.1 against starvation-induced
degradation. In these cells, Cx31.1 appeared in intracellular
punctae that co-localized with the autophagic marker LC3
upon starvation. An unbiased mass spectrometry analysis
of GFP-Cx31.1 immunoprecipitated samples revealed cla-
thrin as a potential Cx31.1-binding partner, confirmed in
direct co-immunoprecipitation assays. Cx31.1 and clathrin
co-localized in cells, including in intracellular punctae that
became more pronounced in starved cells. Knockdown of
clathrin appeared to augment basal Cx31.1 levels and pre-
vented the starvation-induced decrease of Cx31.1 in these
cells. Hence, this study shows that autophagy may contrib-
ute to the degradation of different connexin isoforms in can-
cer cells, although the impact of restoring Cx31.1 expression
through autophagy inhibition on the oncogenic properties
of these tumors ought to be further characterized.
A further role for altered connexin presence in tumors
linked to autophagy has been observed in keratocystic
odontogenic tumors [94]. In these tumor samples, Cx43
and Cx32 levels were significantly downregulated com-
pared to normal oral mucosa samples. The Cx43 and
Cx32 levels negatively correlated with the expression of
the autophagy markers LC3 and p62. This may imply
that excessive autophagy and upregulation of autophagy
markers linked to both Cx43 and Cx32 degradation
could contribute to the downregulation of Cx43 and
Cx32 in these tumors. Thus, inhibiting autophagy may
have a tumor suppressive potential in these patients by
restoring normal Cx43 and Cx32 levels.
Connexin degradation by autophagy also has been impli-
cated as an escape mechanism of tumor cells for immune
surveillance by natural killer cells [95]. In particular, hyp-
oxic stress, occurring in the tumor micro-environment,
appears to be involved in escaping immune surveillance,
including a suppressed susceptibility of tumor cell lysis by
natural killer cells [96]. While hypoxic stress increased the
total Cx43-protein levels in a HIF1α-driven manner in
melanoma cells, the presence of Cx43 gap junctions at the
immunological synapse between melanoma cells and nat-
ural killer cells was strongly diminished [95]. The decline of
Cx43 gap junctions at the immunological sequence was
dependent on the increased autophagic flux occurring
during hypoxia. Indeed, the presence of Cx43 at the
immunological synapse could be restored by inhibiting
lysosomes or knocking down Atg5. Importantly, inhibiting
autophagy and thus preventing the subsequent degradation
of Cx43 at the immunological synapse was very effective in
restoring the susceptibility of hypoxic melanoma cells
towards natural killer cell-mediated lysis. These findings
were corroborated by the use of the endocytic Cx43Y286A
mutant, which remained present at the immunological
synapse during hypoxic stress and also restored the suscep-
tibility of tumor cells towards lysis by natural killer cells in
hypoxic conditions. Thus, this study suggests that inhibition
of autophagy may serve as a strategy to render tumors
more vulnerable to attacks by the immune system (e.g.
through lysis by natural killer cells) by restoring the pres-
ence of connexin at immunological synapses.
Relevance of connexin degradation by autophagy
The cellular and physiological relevance of connexin deg-
radation by autophagy, in particular in response to stress
conditions like nutrient starvation, remains to be further
explored. In general, it is proposed that autophagy activa-
tion as an initial response to stress serves as a cell survival
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pathway while evading cell death. However, excessive or
prolonged autophagy will lead to and/or contribute to cell
death. Also, autosis, a new form of cell death associated
with high levels of autophagy, has been described [85].
Furthermore, there are several mechanistic links between
autophagy and several cell death processes [85, 97]. For in-
stance, anti-apoptotic Bcl-2 proteins can bind Beclin 1,
thereby preventing its pro-autophagic function and thus
co-regulating apoptosis and autophagy [98]. Also, receptor-
interacting protein kinase-1 (RIPK1), a signaling node in
the control of apoptosis and necroptosis in response to
extrinsic death factors, suppresses basal autophagy by pro-
moting ERK-dependent phosphorylation of TFEB, thereby
suppressing its transcriptional activity that is involved in
the expression of genes with functions in autophagy and
lysosomal biogenesis [99, 100]. Moreover, several proteins
with pro-death functions have been shown to be degraded
by autophagy [85]. For instance, FDA-approved inhibitors
of mTOR decrease RIPK1 and RIPK3 levels in human
renal cell carcinoma cells by activating autophagy, which
underlies their resistance to these mTOR inhibitors [101].
Inhibition of autophagy using the lysosomal inhibitor
chloroquine leads to RIPK1/RIPK3 stabilization in mTOR
inhibitor-treated cells, thereby promoting necroptotic cell
death in these cells. Autophagy also impacts the phosphat-
ase FAP1 (Fas-associated phosphatase 1), which counter-
acts Fas/CD95-induced apoptotic cell death [102]. Cells
with increased autophagy flux display reduced levels of
FAP1, thereby sensitizing these cells to apoptosis elicited
by Fas/CD95 signaling. Finally, also activated caspase 8
has been reported to be sequestered into autophagosomes
and degraded in the lysosomes, thereby rendering Bax-
deficient Hct116 cells resistant to TRAIL-induced apop-
tosis [103]. Inhibiting autophagy restored TRAIL-induced
caspase 8-dependent apoptotic responses in these cells.
Importantly, connexin gap junctions too have been
linked to cell death processes and were shown to be re-
sponsible for the spreading of cell death factors between
neighboring cells involving the diffusion of IP3 as a critical
factor [104, 105]. Connexin hemichannels may mediate
the loss of essential survival factors and release of ATP,
glutamate and prostaglandins as factors that participate in
cell-death spreading through paracrine signaling [106].
Also, Cx43 gap junctions and ATP release contribute in
vivo to the spreading of radiation-induced damage from
the irradiated region (e.g. containing tumor cells) to other
neighboring unexposed regions (e.g. healthy tissues) [107].
In that sense, the increased turnover of connexin proteins
as pro-death signaling complexes by autophagy could be a
manner to prevent cell death or cell death spreading
during these early adaptive responses. Further work using
strategies that favor the stabilization of connexin proteins
during autophagy induction treatments and subsequently
assess the impact on cell viability, susceptibility to cell
death stimuli and cell death spreading should provide
further insights in this process. In addition, Cx43 is also
present in intracellular organelles, including the mitochon-
dria, and can also control cell survival. Yet, their suscepti-
bility towards stress conditions and autophagy degradation
has not yet been studied. For a detailed discussion of the
role of connexins as gap junctions and hemichannels or
their channel-independent functions in controlling cell
death and survival, we wish to refer to different reviews
dealing with these topics [34, 36, 106].
At the physiological level, it will be interesting to under-
stand how autophagy impacts connexin functions as gap
junctions and hemichannels and connexin-mediated sig-
naling processes in native tissues like brain, including the
astroglial network, heart and bone. In particular, the use
of tissue-specific knockouts for autophagy-dependent
genes will be instrumental to unravel the physiological
role of autophagy-dependent regulation of connexins,
connexin-mediated signaling and connexin-controlled
processes in vivo. Also, autophagy has been shown to
decrease during ageing, to be impaired in different path-
ologies including neurodegenerative diseases and to play
an anti-inflammatory role [108, 109]. Now, connexins too
have been implicated in these processes with severe alter-
ations in function and expression in several disease condi-
tions [43, 110, 111]. For instance, the excessive opening of
astroglial hemichannels has been implicated in response
to inflammatory cytokines and amyloid β, leading to neur-
onal cell death [112–114]. Hence, alterations in autophagy
might impact the surface level of connexins in gap junc-
tions and hemichannels in these cell types and thus the
pathophysiological outcome.
Connexins: an emerging negative regulator of
autophagic flux
While autophagy impacts connexin levels, it is also clear
that connexins by themselves can suppress the autophagy
process by recruiting pre-autophagosomal Atg proteins and
PI3K components (Fig. 4b), as recently reported in a
seminal paper by Cuervo and co-workers [115]. Cx43 could
co-localize and associate with Atg16, a marker for pre-
autophagosomal structures. The co-localization of Cx43
with Atg16 was not altered in cells undergoing nutrient
starvation, in cells exposed with 3-MA or in cells lacking
Atg15. The Cx43-Atg16 complex appeared prior to autoph-
agy activation, since it did not contain Atg5. Importantly,
mouse osteoblasts obtained from wild-type versus Cx43-
knockout mice displayed altered autophagy. In the absence
of Cx43, autophagic flux was enhanced with an increase in
the number of autophagic vesicles and of steady state LC3-
II levels. The inhibition of autophagy by Cx43 was inde-
pendent of its ability to form functional gap junctions, since
chemical inhibition of Cx43 gap junctions did not increase
autophagic flux, while GFP-Cx43, a fusion protein that is
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located at the plasma membrane but that fails to form func-
tional gap junctions, was fully capable of inhibiting autoph-
agy. Interestingly, a C-terminally truncated Cx43 protein at
position 258 too could repress autophagy correlating with
its ability to interact with Atg16, while Cx43 truncated at
position 245 failed to repress autophagy and to interact
with Atg16. The 245–258 region also contains a Src-
phosphorylation site. Inhibiting Src activity robustly in-
creased autophagy in Cx43-expressing but not in Cx43-
knockout cells, indicating a role for Src-dependent phos-
phorylation of Cx43 in suppressing autophagy. Besides
Atg16, Cx43 also recruited different components of the
class III PI3K complex. Different members of this initiation
complex, Vps34, Beclin 1 and Vps15, were found to inter-
act with Cx43 in normal, starved or rapamycin-treated
conditions and independent on the expression of Atg5 or
Atg16. Also other connexin isoforms appeared to nega-
tively impact autophagic flux, indicating that many
connexin-family members might serve as general autoph-
agy regulators. Knockdown of Cx26 or Cx32 in MEF cells
resulted in increased autophagy, coinciding with their abil-
ity to bind and recruit Atg16. Agents that promoted acute
internalization of Cx43 also increased autophagic flux in a
Cx43-dependent manner. Indeed, tamoxifen and lindane
increased autophagy in Cx43-expressing cells, but not in
Cx43-knockout cells, which displayed already high autoph-
agy in basal conditions. The internalization of Cx43 also
resulted in a decrease in Cx43-Atg16-complex formation,
while Atg16-positive pre-autophagic compartments be-
came more prevalent. Internalization of Cx43 appeared to
be dependent on the recruitment of Atg9 and Atg14 to-
wards Cx43-enriched plasma membrane regions. Upon
starvation, several Atg9 (multimembrane-spanning pro-
tein) vesicles are redistributed from trans-Golgi network
and interact with phagophores during early steps of autop-
hagosome formation [116]. Both Atg9 and Atg14 must be
present in these regions in a spatiotemporal manner before
Cx43 gap junctions can be internalized and degraded by
autophagy. Interestingly, the presence of Atg9 and Atg14
at the plasma membrane and their interaction with Cx43
was prominently increased upon conditions of serum
starvation, explaining the increased Cx43 internalization
during nutrient starvation. It is interesting to note that
other channels have been implicated as regulators of the
autophagy process by scaffolding/recruiting essential au-
tophagy proteins. For instance, the inositol 1,4,5-trisphos-
phate receptor (IP3R), an intracellular Ca
2+-release channel
located at the endoplasmic reticulum, has been shown to
recruit Beclin 1, thereby limiting its availability for the
PI3K initiation complex and thus suppressing autophagy
[117–119]. However, other studies proposed a stimulatory
role for IP3Rs in autophagy by recruiting Beclin 1, sensitiz-
ing the IP3R channel to its agonist IP3 and promoting
intracellular Ca2+-signaling events that are essential to
upregulate autophagic flux in response to nutrient starva-
tion [120–123].
Further studies have implicated that connexins could
regulate the autophagy pathway. In hippocampal tissues
obtained from rats exposed to traumatic brain injuries,
astrocytic phosphorylated Cx43 levels increased, coincid-
ing with an increase in the autophagic marker LC3-II in
the neurons [124]. Carbenoxolone, a Cx43 gap junction/
hemichannel inhibitor, prevented the increase in phosphor-
ylated Cx43 caused by traumatic brain injury and also
suppressed the increase in LC3-II levels. These experiments
therefore suggested a link between the appearance of phos-
phorylated Cx43 in astrocytes and autophagy induction in
neurons as a potential mechanism for brain injuries. This
was further underpinned by in vivo experiments, in which
both carbenoxolone and 3-MA could alleviate the memory
deficits induced by traumatic brain injuries in an assay test-
ing for spatial memory [125]. This correlated with a partial
reversal of the loss of long-term potentiation in rat hippo-
campal slices induced by traumatic brain injury. Thus, both
increased phosphorylated Cx43 and autophagy appeared to
negatively impact brain function in this setup. At the
molecular level, traumatic brain injury reduced the expres-
sion of the glutamate transporter GLT-1 and increased the
expression of the ionotropic purinergic receptor P2X7R.
Collectively, suppressing Cx43 phosphorylation by carbe-
noxolone, inhibiting P2X7R using oxATP or activating the
GLT-1 transporter were able to counteract traumatic brain
injury-induced Beclin 1 upregulation. Furthermore, phos-
phorylated Cx43 and the upregulation of the P2X7R were
also able to prevent the injury-induced decline in GLT-1
levels. Collectively, these data imply a cascade in which
the accumulation of phosphorylated Cx43 in astrocytes
during brain injury leads to an upregulation of P2X7R,
augmenting ATP release and ATP-induced signaling
processes that result in a decrease in GLT-1 and excessive
activation of the autophagic pathway via a marked upregu-
lation of Beclin 1. This “toxic” signaling cascade appears
to negatively impact brain functions after traumatic injury,
since interfering with either Cx43 or autophagy is able to
partially restore neuronal functions. However, the molecu-
lar mechanisms by which elevated levels of phosphory-
lated Cx43 in astrocytes upregulate autophagy in neurons
require further studies.
Conclusions
There is increasing evidence that autophagy and connexins
are interrelated. On the one hand, autophagy is emerging
as an important connexin-degradation pathway not only
under basal and normal growth conditions and well-
established autophagy-inducing conditions like nutrient
starvation but also in a variety of pathological conditions.
Autophagic degradation of Cx43 critically depends on
Cx43 internalization, thereby requiring ubiquitination (e.g.
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by Nedd4), ubiquitin-binding proteins (e.g. Eps15), interac-
tions with autophagic cargo proteins (e.g. p62), autophago-
some markers (e.g. LC3) and other autophagy proteins that
act early on in the process (e.g. Atg9 and Atg14). Further-
more, the degradation by autophagy is not limited to Cx43
but seems to contribute to the rapid turnover of many
connexin isoforms, in particular during conditions of
autophagy activation like nutrient starvation. In addition,
autophagy is also important for the rapid turnover of mu-
tant connexins associated with severe human diseases and
altered autophagy in pathophysiological conditions can lead
to impaired or enhanced connexin degradation. On the
other hand, connexins are also emerging as novel negative
regulators of the autophagy process by recruiting essential
autophagy proteins to the plasma membrane, including
Atg16 and PI3K-complex components like Vps34, Beclin 1
and Vps15 that act in the earlier steps of the autophagy
process. As such, connexins can be limiting their availability
for inducing autophagy upstream of autophagosome forma-
tion. As highlighted by Cuervo and co-workers [71, 115],
the important interplay between connexins and autophagy
is underscored by the fact that many connexin-associated
diseases have been linked with altered autophagy, in-
cluding cardiovascular diseases, ocular diseases, dia-
betes and cancer.
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